臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 301-325 of 599 (24 Page(s) Totally)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-08-12T08:25:31Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-12T08:25:31Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-12T08:25:30Z	Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection	Yang P.-C.; Kuo P.-H.; Wu J.-Y.; SHANG-GIN WU; Sun H.-Y.
臺大學術典藏	2020-08-12T08:25:26Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU
臺大學術典藏	2020-08-12T06:35:29Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y.;Chong-Jen Yu;Shih J.-Y.;Yang C.-H.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-08-12T06:35:23Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Yang P.-C.; Wu J.-Y.;Shih J.-Y.;Chen K.-Y.;Yang C.-H.;Chong-Jen Yu;Yang P.-C.; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:35:22Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.;Chong-Jen Yu;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-12T06:35:14Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:35:08Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; Chang Y.-L.; Hu F.-C.; Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Chong-Jen Yu;Chang Y.-C.;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.
臺大學術典藏	2020-08-12T02:50:56Z	Adrenal insufficiency in prolonged critical illness	Wu J.-Y.;Hsu S.-C.;Ku S.-C.;Chao-Chi Ho;Yu C.-J.;Yang P.-C.; Yang P.-C.; Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO; Yu C.-J.
臺大學術典藏	2020-07-21T06:46:34Z	Adrenal insufficiency in prolonged critical illness	Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO; Yu C.-J.; Yang P.-C.
臺大學術典藏	2020-07-21T06:46:33Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; CHAO-CHI HO; Yu C.-J.; Yang P.-C.
臺大學術典藏	2020-07-01T07:39:42Z	Methyl-directed repair of mismatched small heterologous sequences in cell extracts from Escherichia coli	Woei-Horng Fang;Wu J.-Y.;Su M.-J.; WOEI-HORNG FANG; Wu J.-Y.; Su M.-J.
臺大學術典藏	2020-06-30T05:45:19Z	Regulation of cyst wall protein promoters by Myb2 in Giardia lamblia	Huang Y.-C.;Su L.-H.;Lee G.A.;Chiu P.-W.;Cho C.-C.;Wu J.-Y.;Chin-Hung Sun; Huang Y.-C.; Su L.-H.; Lee G.A.; Chiu P.-W.; Cho C.-C.; Wu J.-Y.; CHIN-HUNG SUN
淡江大學	2020-05-31	Leveraging IT–Enabled Service Innovation in a Highly Competitive Market	Shang, S. S.-C.;Wu, Ya-Ling;Wu, J.-Y.;Chen, C.-C.
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:16Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:16Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:13Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.

Showing items 301-325 of 599 (24 Page(s) Totally)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2831766
	???header.visitor??? : 33361286 ???header.onlineuser??? : 858 ???header.sponsordeclaration???